We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XOXO
1901
DELISTED
Xo Group Inc
XOXO
| $1.09M | ﹤0.01% |
59,142
+7,374
| +14% | +$143K |
|
1902
FormFactor
FORM
$8.28B
| $1.09M | ﹤0.01% |
69,719
-12,902
| -16% | -$216K |
|
|
HSII
1903
DELISTED
Heidrick & Struggles
HSII
| $1.09M | ﹤0.01% |
44,433
+6,151
| +16% | +$144K |
|
|
BKMU
1904
DELISTED
Bank Mutual Corp
BKMU
| $1.09M | ﹤0.01% |
102,399
+12,470
| +14% | +$130K |
|
1905
DXP Enterprises
DXPE
$2.43B
| $1.09M | ﹤0.01% |
36,825
+5,190
| +16% | +$151K |
|
|
SRG
1906
Seritage Growth Properties
SRG
$136M
| $1.09M | ﹤0.01% |
26,913
-4,487
| -14% | -$187K |
|
1907
Gray Television
GTN
$415M
| $1.09M | ﹤0.01% |
64,919
-11,690
| -15% | -$183K |
|
1908
Schneider National
SNDR
$6.26B
| $1.08M | ﹤0.01% |
37,921
-407
| -1% | -$10.5K |
|
1909
ProPetro Holding
PUMP
$1.36B
| $1.08M | ﹤0.01% |
53,642
+23,677
| +79% | +$401K |
|
1910
Q2 Holdings
QTWO
$3.8B
| $1.08M | ﹤0.01% |
29,346
-5,600
| -16% | -$229K |
|
|
LION
1911
DELISTED
Fidelity Southern Corporation
LION
| $1.08M | ﹤0.01% |
49,585
+7,452
| +18% | +$165K |
|
1912
Theravance Biopharma
TBPH
$874M
| $1.08M | ﹤0.01% |
38,654
-7,664
| -17% | -$227K |
|
|
SAFE
1913
Safehold
SAFE
$1.16B
| $1.08M | ﹤0.01% |
19,578
-2,552
| -12% | -$144K |
|
|
CCRN
1914
DELISTED
Cross Country Healthcare
CCRN
| $1.07M | ﹤0.01% |
84,226
+12,621
| +18% | +$167K |
|
1915
Forrester Research
FORR
$223M
| $1.07M | ﹤0.01% |
24,300
+2,850
| +13% | +$128K |
|
|
COTV
1916
DELISTED
Cotiviti Holdings, Inc.
COTV
| $1.07M | ﹤0.01% |
33,286
-5,554
| -14% | -$184K |
|
1917
Argan
AGX
$8B
| $1.07M | ﹤0.01% |
23,780
-3,452
| -13% | -$206K |
|
|
AAMI
1918
Acadian Asset Management
AAMI
$3.08B
| $1.07M | ﹤0.01% |
63,636
-4,126
| -6% | -$65.5K |
|
|
CHUY
1919
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.06M | ﹤0.01% |
37,773
+5,564
| +17% | +$132K |
|
|
HIBB
1920
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.05M | ﹤0.01% |
51,739
+6,811
| +15% | +$112K |
|
|
MSFG
1921
DELISTED
MainSource Financial Group Inc
MSFG
| $1.05M | ﹤0.01% |
29,069
-4,172
| -13% | -$156K |
|
|
DERM
1922
DELISTED
Dermira, Inc.
DERM
| $1.05M | ﹤0.01% |
37,738
-6,643
| -15% | -$176K |
|
1923
Houlihan Lokey
HLI
$8.77B
| $1.05M | ﹤0.01% |
23,058
-2,602
| -10% | -$111K |
|
1924
BancFirst
BANF
$3.79B
| $1.04M | ﹤0.01% |
20,418
-3,002
| -13% | -$166K |
|
|
EGRX
1925
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.04M | ﹤0.01% |
19,501
+2,425
| +14% | +$135K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.